Sort
82,697 grants matching “vaccine development”
Biology of the Lung: A Multidisciplinary Program
$965,792David M Center · Boston University Medical Campus · T32 · FY2011 · HL
DCP - Biopharmaceutical Development Program (BDP) Support
$965,760Leonard Freedman · Leidos Biomedical Research, Inc. · N01 · FY2022 · CA
DCP - Biopharmaceutical Development Program (BDP) Support
$965,760Lynn Briscoe · Leidos Biomedical Research, Inc. · N01 · FY2024 · CA
Rapid response to pandemic influenza via multi-antigen RNA-based vaccine
$965,715Jasdave Chahal · Tiba Biotech, Llc · R44 · FY2025 · AI
Rapid response to pandemic influenza via multi-antigen RNA-based vaccine
$965,678Jasdave Chahal · Tiba Biotech, Llc · R44 · FY2024 · AI
In-Vitro Culture of Plasmodium falciparum Sporozoites for Malaria Vaccine
$965,661Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2021 · AI
Pre-Clinical HPV16 Antiviral Compound Development
$965,617Christopher Fisher · Nanovir, Llc. · R42 · FY2010 · AI
Personalized Cystic Fibrosis Therapy and Research Center
$965,562Anjaparavanda P Naren · Cincinnati Childrens Hosp Med Ctr · P30 · FY2023 · DK
The Charge Study: Childhood Autism Risks from Genetics and the Environment
$965,562Irva Hertz-Picciotto · University Of California At Davis · R01 · FY2011 · ES
Development
$965,464Ana M Navarro · University Of California, San Diego · U54 · FY2012 · CA
Center for Computational Mass Spectrometry
$965,317Pavel A Pevzner · University Of California, San Diego · P41 · FY2016 · GM
Universal room temperature stable influenza nanovaccine
$965,238Balaji Narasimhan · Iowa State University · R01 · FY2023 · AI
Accelerating discovery of an efficacious Plasmodium vivax multivalent multi-stage vaccine
$965,047John Adams · University Of South Florida · U01 · FY2024 · AI
PfSPZ Vaccines: Quality Systems, Manufacturing, Regulatory, and Clinical Quality and Data Management Support for Product Commercialization
$965,038Stephen Lev Hoffman · Sanaria, Inc. · SB1 · FY2018 · AI
Development of Rapid Diagnostic Tests for Hantaviruses
$964,654Sergio Pichuantes · Novartis Vaccines And Diagnostics, Inc. · U01 · FY2007 · AI
University of Miami Pediatric Perinatal HIV/AIDS Clinical Trails Unit
$964,543Gwendolyn B. Scott · University Of Miami School Of Medicine · UM1 · FY2013 · AI
Engineering Bacteriophage T4 as a Targeted Gene Therapy Drug for in vivo HIV Cure
$964,530Venigalla B. Rao · Catholic University Of America · DP1 · FY2025 · DA
Engineering Bacteriophage T4 as a Targeted Gene Therapy Drug for in vivo HIV Cure
$964,530Venigalla B. Rao · Catholic University Of America · DP1 · FY2024 · DA
Preclinical and clinical studies of an HBV rapid test for FDA Pre-market approval
$964,487Helen H Lee · Diagnostics For The Real World, Ltd · R44 · FY2007 · HL
Improved Treatment of Colorectal Cancer with CF10
$964,465William H Gmeiner · Deep Creek Pharma, Llc · R42 · FY2023 · CA
Recombinant Attenuated Bacterial Vaccines Against Biodefense Agents
$964,143Roy Curtiss · Arizona State University-Tempe Campus · R01 · FY2013 · AI
Recombinant life attenuated vaccine against Argentine hemorrhagic fever
$964,053Slobodan Paessler · University Of Texas Med Br Galveston · R01 · FY2014 · AI
Durable HIV Vaccine Targeting Mucosal Epithelium
$963,873Marie-Claire Elisabeth Gauduin · Texas Biomedical Research Institute · R01 · FY2025 · AI
Role of Innate Immune Dysregulation in the Etiology of Dementia
$963,822Annelise Emily Barron · Stanford University · DP1 · FY2020 · AG
Good Manufacturing Practices Master Cell and Working Cell Banks and GMP Pilot Lot of Prototype Shigella flexneri 2a live vector expressing enterotoxigenic E. coli antigens, CVD 1208S 122
$963,769Eileen M. Barry · University Of Maryland Baltimore · R01 · FY2017 · AI